Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials
The sustained release of small, tumor-targeted cytotoxic drugs is an unmet need in cancer therapies, which usually rely on punctual administration regimens of non-targeted drugs. Here, we have developed a novel concept of protein-drug nanoconjugates, which are packaged as slow-releasing chemically h...
Saved in:
Main Authors: | Naroa Serna (Author), Aïda Falgàs (Author), Annabel García-León (Author), Ugutz Unzueta (Author), Yáiza Núñez (Author), Alejandro Sánchez-Chardi (Author), Carlos Martínez-Torró (Author), Ramón Mangues (Author), Esther Vazquez (Author), Isolda Casanova (Author), Antonio Villaverde (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
by: Yáiza Núñez, et al.
Published: (2023) -
Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
by: Patricia Álamo, et al.
Published: (2020) -
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
by: Naroa Serna, et al.
Published: (2021) -
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
by: Rita Sala, et al.
Published: (2022) -
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors
by: Elisa Rioja-Blanco, et al.
Published: (2022)